Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-04-06

Clinical Trial Update: Vitamin D in the Treatment of Primary Restless Legs Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This entry reports on a Phase 2/3 clinical trial evaluating vitamin D for primary restless legs syndrome. The status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: King Abdulaziz University | Conditions: Restless Legs Syndrome | Phase 2, Phase 3 | Status: UNKNOWN